CUV.AX vs. DIM.PA

Last updated Jun 4, 2026

CUV.AX (Clinuvel Pharmaceuticals Limited) and DIM.PA (Sartorius Stedim Biotech SA) are both stocks. Both are in the Healthcare sector — CUV.AX in Biotechnology, DIM.PA in Medical Instruments & Supplies. Over the past 10 years, CUV.AX returned 7.01%/yr vs 12.41%/yr for DIM.PA. At a 0.07 correlation, their price movements are largely independent.

Performance

CUV.AX vs. DIM.PA - Performance Comparison

The chart below illustrates the hypothetical performance of a A$10,000 investment in Clinuvel Pharmaceuticals Limited (CUV.AX) and Sartorius Stedim Biotech SA (DIM.PA). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

CUV.AX is traded in AUD, while DIM.PA is traded in EUR. To make them comparable, the DIM.PA values have been converted to AUD using the latest available exchange rates.

Returns By Period

In the year-to-date period, CUV.AX achieves a -29.13% return, which is significantly lower than DIM.PA's -21.95% return. Over the past 10 years, CUV.AX has underperformed DIM.PA with an annualized return of 7.01%, while DIM.PA has yielded a comparatively higher 12.41% annualized return.

CUV.AX

• 1D: -1.89%
• 1M: -4.54%
• YTD: -29.13%
• 6M: -27.38%
• 1Y: -10.38%
• 3Y*: -21.15%
• 5Y*: -20.83%
• 10Y*: 7.01%

DIM.PA

• 1D: 0.26%
• 1M: 13.27%
• YTD: -21.95%
• 6M: -24.17%
• 1Y: -13.47%
• 3Y*: -12.24%
• 5Y*: -11.57%
• 10Y*: 12.41%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CUV.AX vs. DIM.PA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CUV.AX Clinuvel Pharmaceuticals Limited	-29.13%	3.82%	-24.38%	-25.96%	-20.20%	21.99%	-21.45%	57.33%	121.24%	9.93%
DIM.PA Sartorius Stedim Biotech SA	-21.95%	17.52%	-18.43%	-17.87%	-36.96%	63.74%	96.06%	67.43%	53.87%	6.77%

Correlation

The correlation between CUV.AX and DIM.PA is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.15
Correlation (3Y) Calculated over the trailing 3-year period	0.08
Correlation (5Y) Calculated over the trailing 5-year period	0.13
Correlation (10Y) Calculated over the trailing 10-year period	0.12
Correlation (All Time) Calculated using the full available price history since Jul 16, 2007	0.07

Return for Risk

CUV.AX vs. DIM.PA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CUV.AX

CUV.AX Risk / Return Rank: 31
CUV.AX Sharpe Ratio Rank: 31
CUV.AX Sortino Ratio Rank: 30
CUV.AX Omega Ratio Rank: 30
CUV.AX Calmar Ratio Rank: 32
CUV.AX Martin Ratio Rank: 31

DIM.PA

DIM.PA Risk / Return Rank: 33
DIM.PA Sharpe Ratio Rank: 34
DIM.PA Sortino Ratio Rank: 31
DIM.PA Omega Ratio Rank: 31
DIM.PA Calmar Ratio Rank: 35
DIM.PA Martin Ratio Rank: 34

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CUV.AX vs. DIM.PA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Clinuvel Pharmaceuticals Limited (CUV.AX) and Sartorius Stedim Biotech SA (DIM.PA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CUV.AX	DIM.PA	Difference
Sharpe ratio: Return per unit of total volatility	-0.23	-0.35	+0.12
Sortino ratio: Return per unit of downside risk	-0.03	-0.26	+0.23
Omega ratio: Gain probability vs. loss probability	1.00	0.97	+0.03
Calmar ratio: Return relative to maximum drawdown	-0.29	-0.37	+0.08
Martin ratio: Return relative to average drawdown	-0.53	-0.75	+0.22
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CUV.AX vs. DIM.PA - Sharpe Ratio Comparison

The current CUV.AX Sharpe Ratio is -0.23, which is higher than the DIM.PA Sharpe Ratio of -0.35. The chart below compares the historical Sharpe Ratios of CUV.AX and DIM.PA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CUV.AX	DIM.PA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.23	-0.35	+0.12
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.44	-0.26	-0.18
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.13	0.32	-0.18
Sharpe Ratio (All Time) Calculated using the full available price history	0.13	0.51	-0.38

Drawdowns

CUV.AX vs. DIM.PA - Drawdown Comparison

The maximum CUV.AX drawdown since its inception was -92.52%, which is greater than DIM.PA's maximum drawdown of -72.84%. Use the drawdown chart below to compare losses from any high point for CUV.AX and DIM.PA.

Drawdown Indicators

	CUV.AX	DIM.PA	Difference
Max Drawdown Largest peak-to-trough decline	-92.52%	-72.84%	-19.68%
Max Drawdown (1Y) Largest decline over 1 year	-35.53%	-35.56%	+0.03%
Max Drawdown (3Y) Largest decline over 3 years	-58.28%	-49.27%	-9.01%
Max Drawdown (5Y) Largest decline over 5 years	-79.57%	-72.84%	-6.73%
Max Drawdown (10Y) Largest decline over 10 years	-80.18%	-72.84%	-7.34%
Current Drawdown Current decline from peak	-80.08%	-66.75%	-13.33%
Average Drawdown Average peak-to-trough decline	-56.63%	-25.01%	-31.62%
Ulcer Index Depth and duration of drawdowns from previous peaks	19.39%	17.85%	+1.54%

Volatility

CUV.AX vs. DIM.PA - Volatility Comparison

Clinuvel Pharmaceuticals Limited (CUV.AX) has a higher volatility of 8.82% compared to Sartorius Stedim Biotech SA (DIM.PA) at 8.35%. This indicates that CUV.AX's price experiences larger fluctuations and is considered to be riskier than DIM.PA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CUV.AX	DIM.PA	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.82%	8.35%	+0.47%
Volatility (6M) Calculated over the trailing 6-month period	31.00%	29.56%	+1.44%
Volatility (1Y) Calculated over the trailing 1-year period	44.40%	37.93%	+6.47%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	46.91%	43.92%	+2.99%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	52.81%	38.71%	+14.10%

Dividends

CUV.AX vs. DIM.PA - Dividend Comparison

CUV.AX's dividend yield for the trailing twelve months is around 0.57%, more than DIM.PA's 0.39% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CUV.AX Clinuvel Pharmaceuticals Limited	0.57%	0.40%	0.41%	0.31%	0.18%	0.09%	0.11%	0.09%	0.11%	0.00%	0.00%	0.00%
DIM.PA Sartorius Stedim Biotech SA	0.39%	0.33%	0.37%	0.60%	0.42%	0.14%	0.12%	0.39%	0.53%	0.70%	0.56%	0.37%

Financials

Frequently Asked Questions

Can I hold both CUV.AX and DIM.PA in my portfolio?

CUV.AX and DIM.PA have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.